COVID-19 Disease & Vaccine Survey in Africa

• Sponsor: Salem Anaesthesia Pain Clinic (Other)
• Overall Status: Recruiting
• CT.gov ID: NCT05950243
• Collaborator: (none)
• Enrollment: 1,000
• Location: 1
• Anticipated Duration (Months): 35.9
• Patients Per Site Per Month: 27.8

Study Details

Study Description

Brief Summary

The COVID-19 pandemic is a public health concern; for which the WHO recommends protective measures and vaccination. There is inadequate data on the impact of COVID-19 vaccination and control measures in Africa. This survey is collecting data about people's knowledge, attitude and compliance regarding COVID-19 disease and vaccines.

Condition or Disease	Intervention/Treatment	Phase
COVID-19; Vaccine Hesitancy	Behavioral: Questionnaire

Detailed Description

The coronavirus disease 2019 (COVID-19) pandemic remains a major public health concern. There is inadequate data on the epidemiology of COVID-19 in Africa. There are emerging COVID-19 variants with high transmissibility and morbidity. The World Health Organization (WHO) recommends protective measures and vaccination; for the control of COVID-19. There is inadequate data on the impact of COVID-19 vaccination and control measures in many nations in Africa.

This study is a survey of specific urban populations in sub-Saharan Africa. The anonymized survey is collecting data about people's knowledge and attitude regarding COVID-19 disease or control measures. The survey is also collecting data about people's knowledge, attitude and compliance regarding COVID-19 vaccines. The study uses a validated questionnaire to collect data. The study aims to inform and improve COVID-19 management or control in Africa.

Study Design

• Study Type: Observational
• Anticipated Enrollment: 1000 participants
• Observational Model: Cohort
• Time Perspective: Prospective
• Official Title: COVID-19 Disease & Vaccine Survey in Sub-Saharan Africa
• Actual Study Start Date: Jan 2, 2021
• Anticipated Primary Completion Date: Dec 31, 2023
• Anticipated Study Completion Date: Dec 31, 2023

Arms and Interventions

Arm	Intervention/Treatment
Urban population Africa Urban population in sub-Saharan Africa	Behavioral: Questionnaire; Questionnaire survey for data collection

Outcome Measures

Primary Outcome Measures

1. Percentage of people who know about COVID-19 prevention [6 months]

   Percentage of people who know about COVID-19 preventive measures

2. Percentage of people who received COVID-19 vaccination [6 months]

   Percentage of people who received COVID-19 vaccination, 1st and 2nd doses

Eligibility Criteria

Criteria

• Ages Eligible for Study: 9 Years to 99 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• urban population in Africa

• people in sub-Saharan Africa town

Exclusion Criteria:

• rural population

• people outside sub-Saharan Africa

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Salem Anaesthesia Pain Clinic	Surrey	British Columbia	Canada	V3S 7J1

Sponsors and Collaborators

• Salem Anaesthesia Pain Clinic

Investigators

• Principal Investigator: Olu Bamgbade, MD,FRCPC, Salem Anaesthesia Pain Clinic

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Salem Anaesthesia Pain Clinic
• ClinicalTrials.gov Identifier: NCT05950243
• Other Study ID Numbers: SalemAnes2021 COVID Africa
• First Posted: Jul 18, 2023
• Last Update Posted: Jul 19, 2023
• Last Verified: Jul 1, 2023

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Keywords provided by Salem Anaesthesia Pain Clinic: COVID-19
• Additional relevant MeSH terms: COVID-19

Study Results

No Results Posted as of Jul 19, 2023